Mercer Global Advisors
HURA

Mercer Global Advisors’s TuHURA Biosciences HURA Stock Holding History

Mercer Global Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.5K Buy
+14,809
New +$18.1K ﹤0.01% 3174

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Mercer Global Advisors's HURA Position: Q1 2026 in Review

Mercer Global Advisors opened a new position in TuHURA Biosciences (HURA) in Q1 2026: 14,809 shares worth $26.5K. The stake represents ﹤0.01% of the portfolio and ranks #3174 among its holdings.

89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Mercer Global Advisors held 14,809 shares of TuHURA Biosciences worth $26.5K as of Q1 2026.
  • TuHURA Biosciences was a new Mercer Global Advisors position in Q1 2026.
  • TuHURA Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #3174 holding.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.